Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Genetics of Parkinson’s Disease and Implications for Clinical Practice
Jacob Day, Stephen Mullin
Genes (2021) Vol. 12, Iss. 7, pp. 1006-1006
Open Access | Times Cited: 151

Showing 1-25 of 151 citing articles:

Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges
Jinming Han, Violeta Chiţu, E. Richard Stanley, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 4
Open Access | Times Cited: 98
Flavonoids: Their putative neurologic roles, epigenetic changes, and gut microbiota alterations in Parkinson’s disease
Yasemin Açar, Duygu Ağagündüz, Paola De Cicco, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115788-115788
Open Access | Times Cited: 71
lncRNA NEAT1: Key player in neurodegenerative diseases
Kun Li, Ziqiang Wang
Ageing Research Reviews (2023) Vol. 86, pp. 101878-101878
Open Access | Times Cited: 67
Proposal for a Biologic Staging System of Parkinson’s Disease
Lana M. Chahine, Kalpana Merchant, Andrew Siderowf, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 3, pp. 297-309
Open Access | Times Cited: 56
Parkinson’s Disease is Predominantly a Genetic Disease
Shen‐Yang Lim, Christine Klein
Journal of Parkinson s Disease (2024) Vol. 14, Iss. 3, pp. 467-482
Open Access | Times Cited: 24
Long Non-Coding RNAs: New Insights in Neurodegenerative Diseases
Adithya Anilkumar, Puneet Vij, Samantha Lopez, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2268-2268
Open Access | Times Cited: 15
Pathology in Parkinson’s Disease
Glenda M. Halliday, Yuhong Fu
Cambridge University Press eBooks (2025), pp. 194-201
Closed Access | Times Cited: 9
One-Carbon Metabolism: Pulling the Strings behind Aging and Neurodegeneration
Eirini Lionaki, Christina Ploumi, Nektarios Tavernarakis
Cells (2022) Vol. 11, Iss. 2, pp. 214-214
Open Access | Times Cited: 62
Neurodegeneration and Neuroinflammation in Parkinson’s Disease: a Self-Sustained Loop
Giuseppe Arena, Karan Sharma, Gideon Agyeah, et al.
Current Neurology and Neuroscience Reports (2022) Vol. 22, Iss. 8, pp. 427-440
Open Access | Times Cited: 48
Proteostasis in Parkinson's disease: Recent development and possible implication in diagnosis and therapeutics
Amrita Kulkarni, Preeti Kumari, Kamatham Pushpa Tryphena, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101816-101816
Closed Access | Times Cited: 39
Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer’s, Parkinson’s, and Huntington’s Diseases and Amyotrophic Lateral Sclerosis
Alexandru Vlad Ciurea, Aurel George Mohan, Razvan-Adrian Covache-Busuioc, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10809-10809
Open Access | Times Cited: 37
Cerebrospinal Fluid–Basic Concepts Review
N. Czarniak, Joanna Kamińska, Joanna Matowicka-Karna, et al.
Biomedicines (2023) Vol. 11, Iss. 5, pp. 1461-1461
Open Access | Times Cited: 34
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
Jiarui Hu, Dan Zhang, Keyue Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115475-115475
Closed Access | Times Cited: 26
An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
Hussaini Adam, Subash C. B. Gopinath, M. K. Md Arshad, et al.
3 Biotech (2023) Vol. 13, Iss. 5
Open Access | Times Cited: 23
Epigenetic modification in Parkinson’s disease
Hao Song, Juanli Chen, Jin Huang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 23
Defining Parkinson’s Disease: Past and Future
Kristína Kulcsarová, Matěj Škorvánek, Ronald B. Postuma, et al.
Journal of Parkinson s Disease (2024) Vol. 14, Iss. s2, pp. S257-S271
Open Access | Times Cited: 11
Artificial intelligence in Parkinson's disease: Early detection and diagnostic advancements
Aananya Reddy, Ruhananhad P. Reddy, Aryan Kia Roghani, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102410-102410
Closed Access | Times Cited: 10
Motor and Non‐motor Outcomes of Deep Brain Stimulation across the Genetic Panorama of Parkinson's Disease: A Multi‐Scale Meta‐Analysis
Evridiki Asimakidou, Georgia Xiromerisiou, Christos Sidiropoulos
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 5, pp. 465-477
Closed Access | Times Cited: 9
Parkinson’s Disease: Cells Succumbing to Lifelong Dopamine-Related Oxidative Stress and Other Bioenergetic Challenges
Hirohisa Watanabe, Johannes M. Dijkstra, Toshiharu Nagatsu
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2009-2009
Open Access | Times Cited: 8
Toward a biological definition of neuronal and glial synucleinopathies
Claudio Soto, Brit Mollenhauer, Oskar Hansson, et al.
Nature Medicine (2025)
Closed Access | Times Cited: 1
Roles of clock genes in the pathogenesis of Parkinson's disease
Anastasiia D. Shkodina, Shing Cheng Tan, Mohammad Mehedi Hasan, et al.
Ageing Research Reviews (2021) Vol. 74, pp. 101554-101554
Closed Access | Times Cited: 54
Genetically transitional disease: a new concept in genomic medicine
Qingping Yao, Peter D. Gorevic, Bo Shen, et al.
Trends in Genetics (2022) Vol. 39, Iss. 2, pp. 98-108
Closed Access | Times Cited: 28
Alpha-Synuclein Contribution to Neuronal and Glial Damage in Parkinson’s Disease
Kamil Saramowicz, Natalia Siwecka, Grzegorz Galita, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 360-360
Open Access | Times Cited: 21
TIM23 facilitates PINK1 activation by safeguarding against OMA1-mediated degradation in damaged mitochondria
Shiori Akabane, Kiyona Watanabe, Hidetaka Kosako, et al.
Cell Reports (2023) Vol. 42, Iss. 5, pp. 112454-112454
Open Access | Times Cited: 19
A Preclinical Model for Parkinson’s Disease Based on Transcriptional Gene Activation via KEAP1/NRF2 to Develop New Antioxidant Therapies
Juan Segura‐Aguilar, Bengt Mannervik
Antioxidants (2023) Vol. 12, Iss. 3, pp. 673-673
Open Access | Times Cited: 18
Page 1 - Next Page

Scroll to top